Key Drivers
- High gross margin
- Cash-positive ops
- Heavy SG&A
AIAI Summary
FIGS now looks like a cash-generative, brand-resilient growth story but is a "growth-at-risk" investment—near-term solvency is secure yet upside is tightly contingent on management materially mitigating rising tariff/freight headwinds to prevent a meaningful gross-margin and EBITDA re-rate. Action: treat as watch/hold until the company provides clear evidence of tariff mitigation (supply-chain redesign, cost pass-through, or sustained margin recovery) or materially better SG&A leverage.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High gross margin
- •Cash-positive ops
- •Heavy SG&A
FIGS has a very strong balance sheet and healthy cash generation but elevated operating expenses and rich valuation are constraining net returns and warrant monitoring.
Price Behavior
Key Price Behavior Insights:
- •Short‑term weakness
- •Oversold bounce potential
- •Lower highs trend
FIGS is trading below its last month average after a March peak, sitting near $14.20 with very low RSI (mid‑teens) suggesting an oversold bounce is possible but the pattern of lower highs risks a drop toward the $10.90–$11.00 support zone if selling resumes.
Drop from ~ $17.12 peak in early
Sentiment & News
Key News Insights:
- •Strong top‑line
- •EPS beat
- •Valuation risk
FIGS beat Q4 2025 estimates (rev +33%, EPS $0.10), sparked a rally to a 52‑week high while analysts caution valuation pullback risk, and signaled policy engagement via the Healthcare is Human Act.
The print and margin commentary likely sustain short‑term upside and investor interest, but elevated price targets increase downside risk if growth decelerates
Similar Companies in Consumer Cyclical
Other companies in the same sector with AI ratings